FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency

Links shared publicly online about this topic.

  • 1,708
    total visits

FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency

fda.gov

The U.S. Food and Drug Administration today alerted health care professionals to a change in heparin manufacturing that is expected to decrease the potency of the common anti-clotting drug.

View full resource at fda.gov

Tags: Drug, Healthcare, FDA, Anti-Clotting Medication

  • Share

Most Recently Shared on October 10, 2009 at 9:09 pm By:

mauron M Auron MD

Less potent heparin due to new USP standards - may need increased dosage - just monitor the PTT! - http://bit.ly/Q6giX

3 years ago...

Also Shared By:

U-M Health System U-M Health System

Barbara Olson Barbara Olson

FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency

usrecallnews.com — “Healthcare providers should be aware of the potency change for heparin products and the possible clinical effects of this decrease in potency per USP unit dose.View full resource at usrecallnews.com

  • View Related
  • Share

Most Recently Shared on October 2, 2009 at 8:48 pm By:

usrecallnews usrecallnews Health News

FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency http://bit.ly/2qh7vN

3 years ago...

FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency - Drugs.com MedNews

drugs.com — “Adjustments may be needed to achieve desired anticoagulant effect in some patients New Heparin to Ship Starting October 8 The U.S. Food and Drug Administration View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 2, 2009 at 8:02 pm By:

drugscom Drugs.com Health Site

FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency - http://bit.ly/4D7aEq

3 years ago...

Advertisement